share_log

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair

SEC announcement ·  Apr 15 16:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more